Company Introduction: Nigale
Nigale, co-founded by the Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital in September 1994, was reformed into a private company in July 2004 and officially joined China Resources Pharmaceutical Group, a subsidiary of China Resources Group, in January 2025. For over 20 years, Nigale has achieved numerous milestones, establishing itself as a pioneer in the blood transfusion industry in China.
Nigale offers a comprehensive portfolio of blood management devices, disposable kits, medicines, and software, providing full-solution plans for plasma centers, blood centers, and hospitals. Our innovative product line includes the Blood Component Apheresis Separator, Blood Cell Separator, Disposable Room-Temperature Platelet Preservation Bag, Intelligent Blood Cell Processor, and Plasma Apheresis Separator, among others.
Company Profile
By the end of 2025, Nigale had obtained more than 300 patents, showcasing our commitment to innovation and excellence. We have independently invented numerous products that have significantly advanced the field of blood transfusion. Additionally, Nigale has organized and participated in legislating over 10 national industrial standards. Many of our products have been recognized as national key new products, part of the national torch plan, and included in national innovation programs.
Company Profile
Nigale is one of the top manufacturers of plasma disposable sets worldwide, with our products sold in more than 40 countries across Europe, Asia, Latin America, and Africa.
Our strong technical support from the Institute of Blood Transfusion and Hematology of the Chinese Academy of Medical Sciences and the Sichuan Provincial Academy of Medical Sciences ensures that we remain at the forefront of technological advancements. All Nigale products are certified by the Chinese NMPA, ISO 13485, and CE, meeting the international standards for quality and safety.
Nigale’s focus on one primary field—blood transfusion—is complemented by our three main product categories: devices, disposables, and software/services. We serve critical markets including plasma centers, blood centers/banks, and hospitals, ensuring that our comprehensive solutions meet the diverse needs of these sectors.
Since beginning exports in 2008, Nigale has grown to employ over 1,000 dedicated professionals who drive our mission to enhance patient care and outcomes globally. Our products are widely used in blood cell separation and filtration, plasma exchange therapy, and in operating rooms and clinical therapies in hospitals.
Nigale continues to lead the blood transfusion industry through innovation, quality, and a steadfast commitment to excellence, aiming to make a significant impact on global healthcare.
